• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff

  • Print
  • Share
  • E-mail
-

Search Publications



Fields



Centers











Starting Date


Ending Date


Order by

Entry Details

Expert Rev Gastroenterol Hepatol 2014 May 23 [Epub ahead of print]

Predicting idiosyncratic drug-induced liver injury - some recent advances.

Chen M, Borlak J, Tong W

Abstract

Drug-induced liver injury (DILI) is a major challenge for the pharmaceutical industry, regulatory authorities, and clinicians. It is usually categorized into 'intrinsic' and 'idiosyncratic', but DILI caused by most drugs is of an idiosyncratic nature and usually cannot be predicted from the regulatory required animal toxicity studies. Unfortunately, some individuals exposed to therapeutic dose will develop idiosyncratic DILI that might involve severe clinical outcome, and no biomarker is available to identify the susceptible patients prior to drug treatment. In this editorial, we summarized the recent advances in predicting idiosyncratic DILI and provided the perspectives to improve the prediction.


Category: Journal Article, Editorial
PubMed ID: #24857265 DOI: 10.1586/17474124.2014.922871
Includes FDA Authors from Scientific Area(s): Toxicological Research
Entry Created: 2014-05-27
Feedback
-
-